🇺🇸 FDA
Patent

US 9770510

Etanercept formulations stabilized with xylitol

granted A61KA61K38/17A61K38/1793

Quick answer

US patent 9770510 (Etanercept formulations stabilized with xylitol) held by Coherus BioSciences, Inc. expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Coherus BioSciences, Inc.
Grant date
Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/17, A61K38/1793, A61K38/191, A61K39/39591